Zacks Investment Research
04 Jun 2026, 17:45 UTC · 3h ago
3 Reasons Why Growth Investors Shouldn't Overlook HealthEquity (HQY)
Search tags
Zacks Investment Research
04 Jun 2026, 17:45 UTC · 3h ago
Search tags
Story key points
2 claims · impact-rated
HealthEquity (HQY) is projected to have earnings per share (EPS) growth of 15.7% this year, exceeding the industry average of 11.7%. — Above-average earnings growth relative to peers is a positive fundamental catalyst for a specific equity.
+0.40HealthEquity (HQY) has a historical EPS growth rate of 45.8%. — Strong historical growth supports the company's growth profile, though forward-looking data is more material.
+0.20Ticker attribution
Model heads
The company is explicitly recommended as a great growth pick with a top Zacks Rank and projected earnings growth that crushes the industry average.
Continue reading
6 related stories
No ticker relationship head found.
Early access
News Impact Screener scores every headline against the stocks it moves — before the chart reacts. Join the early-access list and get alerted the moment a story hits your tickers.
Impact vectors
1 dimensions · 9 clusters
Market reaction
10 bid · 0 offered
No stock impact ranking available yet.
Zacks Investment Research
3h ago
